原发性免疫缺陷的造血干细胞移植
Hematopoietic stem cell transplantation for primary immunodeficiencies.
作者信息
Kang Elizabeth, Gennery Andrew
机构信息
Hematotherapeutics Unit, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 10-CRC Room 6-3752, 10 Centre Drive, Bethesda, MD 20892, USA.
Paediatric Immunology Department, Institute of Cellular Medicine, Great North Children's Hospital, c/o Ward 3, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK.
出版信息
Hematol Oncol Clin North Am. 2014 Dec;28(6):1157-70. doi: 10.1016/j.hoc.2014.08.006. Epub 2014 Sep 16.
Abstract
Allogeneic hematopoietic stem cell transplantation has been shown to be curative for well-described as well as newly discovered immunodeficiencies. However, it is difficulty to define a universal transplant regimen given the rarity of these disorders and the varied pathophysiology these disorders encompass. This article discusses those primary immunodeficiencies most commonly treated by hematopoietic stem cell transplant and describes the transplant issues specific to these disorders.
摘要
同种异体造血干细胞移植已被证明对已明确描述的以及新发现的免疫缺陷具有治愈作用。然而，鉴于这些疾病的罕见性以及它们所包含的不同病理生理学特征，很难确定一种通用的移植方案。本文讨论了那些最常通过造血干细胞移植治疗的原发性免疫缺陷，并描述了这些疾病特有的移植问题。
相似文献
1
Hematopoietic stem cell transplantation for primary immunodeficiencies.
Hematol Oncol Clin North Am. 2014 Dec;28(6):1157-70. doi: 10.1016/j.hoc.2014.08.006. Epub 2014 Sep 16.
2
[Hematopoietic stem cell transplantation in children with primary immunodeficiencies].
Acta Med Croatica. 2009 Jun;63(3):255-8.
3
Stem-cell transplantation for primary immunodeficiencies.
Isr Med Assoc J. 2002 Aug;4(8):648-52.
4
Allogeneic stem cell transplantation for treatment of immunodeficiency.
Springer Semin Immunopathol. 2004 Nov;26(1-2):109-18. doi: 10.1007/s00281-004-0158-2. Epub 2004 Sep 11.
5
Allogeneic Hematopoietic Cell Transplantation in Patients with Primary Immunodeficiencies in Korea: Eleven-Year Experience in a Single Center.
J Clin Immunol. 2018 Oct;38(7):757-766. doi: 10.1007/s10875-018-0542-7. Epub 2018 Aug 27.
6
Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
Biol Blood Marrow Transplant. 2010 Jun;16(6):818-23. doi: 10.1016/j.bbmt.2010.01.002. Epub 2010 Jan 14.
7
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Patients in the Black Sea Region of Turkey.
Turk J Haematol. 2017 Dec 1;34(4):345-349. doi: 10.4274/tjh.2016.0477. Epub 2017 Apr 13.
8
Allogeneic stem cell transplantation in adolescents and young adults with primary immunodeficiencies.
J Allergy Clin Immunol Pract. 2018 Jan-Feb;6(1):298-301.e2. doi: 10.1016/j.jaip.2017.07.045. Epub 2017 Sep 22.
9
Advances in hematopoietic stem cell transplantation for primary immunodeficiency.
Expert Rev Clin Immunol. 2013 Oct;9(10):991-9. doi: 10.1586/1744666X.2013.836061.
10
Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.
Biol Blood Marrow Transplant. 2015 Nov;21(11):1955-62. doi: 10.1016/j.bbmt.2015.07.008. Epub 2015 Jul 15.
引用本文的文献
1
Primary immunodeficiencies (PID) Life Index in Southeast Asia: A comparative analysis of PID Principles of Care (PoC).
Front Immunol. 2023 Mar 30;14:1151335. doi: 10.3389/fimmu.2023.1151335. eCollection 2023.
2
The PID Principles of Care: Where Are We Now? A Global Status Report Based on the PID Life Index.
Front Immunol. 2021 Nov 18;12:780140. doi: 10.3389/fimmu.2021.780140. eCollection 2021.
3
Current status and prospects of primary immunodeficiency diseases in Asia.
Genes Dis. 2019 Sep 12;7(1):3-11. doi: 10.1016/j.gendis.2019.09.004. eCollection 2020 Mar.
4
Gonadal failure among female patients after hematopoietic stem cell transplantation for non-malignant diseases.
Clin Pediatr Endocrinol. 2019;28(4):105-112. doi: 10.1297/cpe.28.105. Epub 2019 Oct 19.
5
Successful Hematopoietic Stem Cell Transplantation in a Patient with LPS-Responsive Beige-Like Anchor (LRBA) Gene Mutation.
J Clin Immunol. 2016 Jul;36(5):480-9. doi: 10.1007/s10875-016-0289-y. Epub 2016 May 4.
本文引用的文献
1
Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency.
Front Immunol. 2014 Apr 22;5:162. doi: 10.3389/fimmu.2014.00162. eCollection 2014.
2
Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency.
J Allergy Clin Immunol. 2014 Jun;133(6):1660-6. doi: 10.1016/j.jaci.2014.02.042. Epub 2014 May 1.
3
Haploidentical stem cell transplantation in DOCK8 deficiency - Successful control of pre-existing severe viremia with a TCRaß/CD19-depleted graft and antiviral treatment.
Clin Immunol. 2014 May-Jun;152(1-2):111-4. doi: 10.1016/j.clim.2014.03.006. Epub 2014 Mar 22.
4
Single centre experience of haematopoietic SCT for patients with immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Bone Marrow Transplant. 2014 Feb;49(2):310-2. doi: 10.1038/bmt.2013.181. Epub 2013 Nov 25.
5
Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.
Lancet. 2014 Feb 1;383(9915):436-48. doi: 10.1016/S0140-6736(13)62069-3. Epub 2013 Oct 23.
6
SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
Blood. 2014 Jan 9;123(2):281-9. doi: 10.1182/blood-2013-01-476432. Epub 2013 Oct 21.
7
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.
Biol Blood Marrow Transplant. 2013 Aug;19(8):1238-43. doi: 10.1016/j.bbmt.2013.05.021. Epub 2013 Jun 8.
8
Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure.
Bone Marrow Transplant. 2013 Sep;48(9):1168-72. doi: 10.1038/bmt.2013.35. Epub 2013 Apr 1.
9
Long-term outcome of non-ablative booster BMT in patients with SCID.
Bone Marrow Transplant. 2013 Aug;48(8):1050-5. doi: 10.1038/bmt.2013.6. Epub 2013 Feb 11.
10
Multiple osteochondromas following irradiation-containing conditioning in severe combined immunodeficiency.
Br J Haematol. 2013 May;161(3):446-8. doi: 10.1111/bjh.12248. Epub 2013 Feb 6.
Zotero 插件